Cancer and mTOR inhibitors in kidney transplantation recipients

Background Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. Methods In the current study, patients were registered into...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chih-Chin Kao, Jia-Sin Liu, Yu-Kang Chang, Ming-Huang Lin, Yen-Chung Lin, Hsi-Hsien Chen, Wei-Chiao Chang, Chih-Cheng Hsu, Mai-Szu Wu
Médium: Artigo
Jazyk:Inglês
Vydáno: PeerJ Inc. 2018-11-01
Edice:PeerJ
Témata:
Chronic kidney disease
Cancer
Kidney transplantation
Mortality
mTOR inhibitors
On-line přístup:https://peerj.com/articles/5864.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky